GSK and Fleming Initiative scientists unite to target AMR with advanced AI
Imperial wins Outstanding Entrepreneurial University at THE Awards
Imperial celebrates impact of supporters who gave £77.5 million in 2024-25
Advancing research in the prediction, prevention, and treatment of Hypoxic-Ischemic Encephalopathy (HIE) to improve newborn outcomes.
Click here to know more about us
Our research prioritizes prevention, MRI-based biomarkers, neuroprotection, and AI-driven predictions to improve perinatal brain health.
Read more about our themes
We conduct cutting-edge clinical trials to advance neonatal neuroprotection, supported by leading funding bodies.
Read more about our clinical trials
We support PhD research globally, fostering innovation in neonatal care and advancing methodologies to improve outcomes.
Learn more about our PhD projects